Camaric acid



Compound IDCDAMM01424
Common nameCamaric acid
IUPAC name20-hydroxy-8,8,14,15,19,19-hexamethyl-10-(2-methylbut-2-enoyloxy)-21-oxahexacyclo[18.2.2.01,18.02,15.05,14.06,11]tetracos-4-ene-11-carboxylic acid
Molecular formulaC35H52O6

Experimental data

Retention time14.7
Adduct[M+H]+
Actual mz569.377
Theoretical mz569.383
Error10.5
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.0686

Identifiers and class information

Inchi keyRSKOPEQHBSFOLQ-CNDNMLNVNA-N
SmilesO=C(OC1CC(C)(C)CC2C3=CCC4C(C)(CCC5C(C)(C)C6(O)OCC45CC6)C3(C)CCC12C(=O)O)C(=CC)C
SuperclassLipids and lipid-like molecules
ClassPrenol lipids

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)1
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)4
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-1
Molecular weight (mol_MW)568.792
Computed dipole moment(dipole)6.441
Total solvent accessible surface area (SASA)832.149
Hydrophobic component of SASA (FOSA)686.015
Hydrophilic component of SASA (FISA)116.215
Pie component of the SASA (PISA)29.918
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1689.89
Number of hydrogen bond donors (donorHB)2
Number of hydrogen bond acceptors (accptHB)5.5
Free energy of solvation of dipole (dip^2/V)0.0245468
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0093471
Globularity descriptor (glob)0.824523
Predicted polarizability in cubic angstroms (QPpolrz)59.193
Predicted hexadecane/gas partition coefficient (QPlogPC16)15.163
Predicted octanol/gas partition coefficient (QPlogPoct)25.933
Predicted water/gas partition coefficient (QPlogPw)10.18
Predicted octanol/water partition coefficient (QPlogPo/w)7.203
Predicted aqueous solubility (QPlogS)-8.587
Conformation-independent predicted aqueous solubility (CIQPlogS)-8.602
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-2.707
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)198.348
Predicted brain/blood partition coefficient (QPlogBB)-0.817
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)109.494
Predicted skin permeability, log Kp (QPlogKp)-3.172
PM3 calculated ionization potential (IP(ev))9.973
PM3 calculated electron affinity (EA(eV))-0.03
Number of likely metabolic reactions (#metab)4
Prediction of binding to human serum albumin (QPlogKhsa)1.757
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)84.321
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)101.567
Number of nitrogen and oxygen atoms (#NandO)6
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P29350PTPN6Protein-tyrosine phosphatase 1CT98264SEA
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SEA
P17706PTPN2T-cell protein-tyrosine phosphataseT49156SEA
P06746POLBDNA polymerase beta (by homology)T06958SEA
P13726F3Coagulation factor VII/tissue factorT72702SEA
Q07817BCL2L1Apoptosis regulator Bcl-XT56510SwissTargetPrediction
O15111CHUKInhibitor of NF-kappa-B kinase (IKK)T78429SwissTargetPrediction

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1
T49156DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P17706PTPN2
T06958DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P06746POLB
T72702DI0075Cervical cancer[ICD-11: 2C77]P13726F3
T56510DI0286Myeloproliferative neoplasm[ICD-11: 2A20]Q07817BCL2L1
T78429DI0250Mature B-cell lymphoma[ICD-11: 2A85]O15111CHUK

Copyright © 2025